Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Myxoid Liposarcoma”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686367
What this trial is testing

Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Synovial SarcomaUnresectable Myxoid Liposarcoma+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT06843967
What this trial is testing

Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Who this might be right for
Well Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)UnknownNCT04356872
What this trial is testing

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Fudan University 45
Testing effectiveness (Phase 2)WithdrawnNCT03397186
What this trial is testing

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaStage III Soft Tissue Sarcoma AJCC v7+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Testing effectiveness (Phase 2)Study completedNCT00112463
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT05993299
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM, LLC (dba US WorldMeds) 7
Testing effectiveness (Phase 2)Study completedNCT02249949
What this trial is testing

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Who this might be right for
Liposarcoma
Alliance for Clinical Trials in Oncology 15
Testing effectiveness (Phase 2)Study completedNCT02821507
What this trial is testing

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Who this might be right for
Conventional ChondrosarcomaMyxoid LiposarcomaMesenchymal Chondrosarcoma+1 more
Leiden University Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT03063632
What this trial is testing

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Round Cell LiposarcomaMetastatic Synovial Sarcoma+13 more
National Cancer Institute (NCI) 28
Early research (Phase 1)Active Not RecruitingNCT06414434
What this trial is testing

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Who this might be right for
LiposarcomaRecurrent LiposarcomaMetastatic Liposarcoma+4 more
Michael Wagner, MD 24
Early research (Phase 1)Ended earlyNCT05943990
What this trial is testing

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
Adaptimmune 5
Testing effectiveness (Phase 2)Study completedNCT06703346
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM CT, LLC 82
Early research (Phase 1)Ended earlyNCT06048705
What this trial is testing

Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Neoplasms
Adaptimmune 7